🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07425379
Starting soon Not applicable

Prehabilitation in Breast Cancer Surgery

NCT07425379 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-03-01
Last updated
2026-02-24

Condition(s) studied

Breast Cancer (Early Breast Cancer)Postoperative Shoulder DysfunctionLymphedema ArmCancer Rehabilitation

Investigational drug(s) / intervention(s)

Home-Based Prehabilitation Exercise ProgramUsual Care

Home-Based Prehabilitation Exercise Program: Participants assigned to this arm will receive a structured, home-based prehabilitation program initiated at least three weeks prior to surgery. The intervention includes: (1) moderate-intensity aerobic exercise (3 sessions per week, 30 minutes per session, target intensity RPE 4-6/10), (2) upper extremity resistance exercises using elastic bands (3 sessions per week, 3 sets of 10 repetitions per exercise), and (3) mobility and stretching exercises focused on shoulder function. The program will be delivered through written materials and instructional exercise videos accessible via QR code. Participants will receive elastic resistance bands for training. Adherence and progression will be monitored weekly via remote follow-up (telephone or email contact). The intervention is non-pharmacological and designed to optimize upper extremity function prior to breast cancer surgery.

Usual Care: Usual Preoperative Care

Study summary

This prospective, randomized, assessor-blinded, parallel-group clinical trial evaluates the effectiveness of a home-based upper extremity-focused prehabilitation program in women undergoing breast cancer surgery. Participants will be randomized 1:1 to either prehabilitation or usual care. Primary outcomes include shoulder range of motion and upper extremity function (DASH score). Secondary outcomes include grip strength, pain, fatigue, disability, anxiety/depression, and lymphedema incidence up to 2 years postoperatively.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: Women aged 18-80 Stage I-III invasive breast cancer Scheduled for surgery ≥3 weeks before surgery No neoadjuvant therapy Exclusion Criteria: Exercise contraindication Active shoulder pathology Severe cardiopulmonary disease Planned neoadjuvant therapy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Dr. Sadi Konuk Bakirkoy Training and Health Hospital Istanbul Istanbul

More Bakirkoy Dr. Sadi Konuk Research and Training Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07425379 on ClinicalTrials.gov ↗ ← All trials in Turkey